Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Cipla
Argus Health
Deloitte
Merck
Healthtrust
Mallinckrodt
US Army
Fish and Richardson
Chinese Patent Office

Generated: January 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,457,133

« Back to Dashboard

Summary for Patent: 5,457,133
Title: R-enantiomers of N-propargyl-aminoindan compounds, their preparation and pharmaceutical compositions containing them
Abstract:R(+)-N-propargyl-1-aminoindan, its preparation and use and pharmaceutical compositions containing it. The novel compound was found to be useful for the treatment of human patients for Parkinson's disease, memory disorders, dementia of the Alzheimer type (DAT), depression and the hyperactive syndrome.
Inventor(s): Youdim; Moussa B. H. (Haifa, IL), Finberg; John P. M. (Tivon, IL), Levy; Ruth (Tel-Aviv, IL), Sterling; Jeffrey (Jerusalem, IL), Lerner; David (Jerusalem, IL), Berger-Paskin; Tirtsah (Raanana, IL), Yellin; Haim (Ramat-Gan, IL)
Assignee: Teva Pharmaceutical Industries Ltd. (Jerusalem, IL) Technion Research and Development Foundation Ltd. (Haifa, IL)
Application Number:08/198,205
Patent Claim Types:
see list of patent claims
Compound; Composition; Dosage form; Formulation;

Drugs Protected by US Patent 5,457,133

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,457,133

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Israel92952Jan 03, 1990

International Patents Family Members for US Patent 5,457,133

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Estonia 9700310 ➤ Subscribe
Estonia 03741 ➤ Subscribe
European Patent Office 0436492 ➤ Subscribe 91195 Luxembourg ➤ Subscribe
European Patent Office 0436492 ➤ Subscribe CA 2005 00040 Denmark ➤ Subscribe
Germany 122005000045 ➤ Subscribe
Israel 118247 ➤ Subscribe
Israel 111240 ➤ Subscribe
Israel 92952 ➤ Subscribe
Ireland 62371 ➤ Subscribe
European Patent Office 0828485 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Express Scripts
Baxter
Boehringer Ingelheim
UBS
Cipla
US Army
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot